Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:srpt | https://www.glassdoor.com?employer_id=632730 | 632730 | Apr 21st, 2024 12:00AM | Open | Sarepta Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 1997 | 4.60 | 98% | 96% | 95% | 4.50 | 4.70 | 4.40 | 4.60 | 4.30 | 4.30 | 2.00 | 1.00 | 6.00 | 11.00 | 43.00 | 63.00 | 79.00 | 77.00 | 3.175% | 1.587% | 9.524% | 17.46% | 68.254% | 0.00 | 51.00 | 148.00 | 0.60 | 0.13 | 0.27 | 0.68 | 0.19 | 0.05 | 0.05 | Open | Douglas S. Ingram | Apr 21st, 2024 04:31PM | Apr 21st, 2024 04:31PM | Sarepta Therapeutics | Health Care | Pharmaceuticals & Biotechnology | male | white | |||||
nasdaq:srpt | https://www.glassdoor.com?employer_id=632730 | 632730 | Apr 20th, 2024 12:00AM | Open | Sarepta Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 1997 | 4.60 | 98% | 96% | 95% | 4.50 | 4.70 | 4.40 | 4.60 | 4.30 | 4.30 | 2.00 | 1.00 | 6.00 | 11.00 | 43.00 | 63.00 | 79.00 | 77.00 | 3.175% | 1.587% | 9.524% | 17.46% | 68.254% | 0.00 | 148.00 | 0.60 | 0.13 | 0.27 | 0.68 | 0.19 | 0.05 | 0.05 | Open | Douglas S. Ingram | Apr 20th, 2024 04:46PM | Apr 20th, 2024 04:46PM | Sarepta Therapeutics | Health Care | Pharmaceuticals & Biotechnology | male | white | ||||||
nasdaq:srpt | https://www.glassdoor.com?employer_id=632730 | 632730 | Apr 19th, 2024 12:00AM | Open | Sarepta Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 1997 | 4.60 | 98% | 96% | 95% | 4.50 | 4.70 | 4.40 | 4.60 | 4.30 | 4.30 | 2.00 | 1.00 | 6.00 | 11.00 | 44.00 | 64.00 | 79.00 | 77.00 | 3.125% | 1.562% | 9.375% | 17.188% | 68.75% | 0.00 | 148.00 | 0.60 | 0.13 | 0.27 | 0.68 | 0.19 | 0.05 | 0.05 | Open | Douglas S. Ingram | Apr 19th, 2024 07:44AM | Apr 19th, 2024 07:44AM | Sarepta Therapeutics | Health Care | Pharmaceuticals & Biotechnology | male | white | ||||||
nasdaq:srpt | https://www.glassdoor.com?employer_id=632730 | 632730 | Apr 18th, 2024 12:00AM | Open | Sarepta Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 1997 | 4.60 | 98% | 96% | 95% | 4.50 | 4.70 | 4.40 | 4.60 | 4.30 | 4.30 | 2.00 | 1.00 | 6.00 | 11.00 | 44.00 | 64.00 | 79.00 | 77.00 | 3.125% | 1.562% | 9.375% | 17.188% | 68.75% | 0.00 | 148.00 | 0.60 | 0.13 | 0.27 | 0.68 | 0.19 | 0.05 | 0.05 | Open | Douglas S. Ingram | Apr 18th, 2024 06:06PM | Apr 18th, 2024 06:06PM | Sarepta Therapeutics | Health Care | Pharmaceuticals & Biotechnology | male | white | ||||||
nasdaq:srpt | https://www.glassdoor.com?employer_id=632730 | 632730 | Apr 17th, 2024 12:00AM | Open | Sarepta Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 1997 | 4.60 | 98% | 96% | 95% | 4.50 | 4.70 | 4.40 | 4.60 | 4.30 | 4.30 | 2.00 | 1.00 | 6.00 | 11.00 | 44.00 | 64.00 | 79.00 | 77.00 | 3.125% | 1.562% | 9.375% | 17.188% | 68.75% | 0.00 | 147.00 | 0.60 | 0.13 | 0.27 | 0.68 | 0.19 | 0.05 | 0.05 | Open | Douglas S. Ingram | Apr 17th, 2024 02:33PM | Apr 17th, 2024 02:33PM | Sarepta Therapeutics | Health Care | Pharmaceuticals & Biotechnology | male | white | ||||||
nasdaq:srpt | https://www.glassdoor.com?employer_id=632730 | 632730 | Apr 16th, 2024 12:00AM | Open | Sarepta Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 1997 | 4.60 | 98% | 96% | 95% | 4.50 | 4.70 | 4.40 | 4.60 | 4.30 | 4.30 | 2.00 | 1.00 | 5.00 | 11.00 | 44.00 | 63.00 | 79.00 | 77.00 | 3.175% | 1.587% | 7.937% | 17.46% | 69.841% | 0.00 | 147.00 | 0.60 | 0.13 | 0.27 | 0.68 | 0.19 | 0.05 | 0.05 | Open | Douglas S. Ingram | Apr 16th, 2024 10:45AM | Apr 16th, 2024 10:45AM | Sarepta Therapeutics | Health Care | Pharmaceuticals & Biotechnology | male | white | ||||||
nasdaq:srpt | https://www.glassdoor.com?employer_id=632730 | 632730 | Apr 15th, 2024 12:00AM | Open | Sarepta Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 1997 | 4.60 | 98% | 96% | 95% | 4.50 | 4.70 | 4.40 | 4.60 | 4.30 | 4.30 | 2.00 | 1.00 | 5.00 | 11.00 | 44.00 | 63.00 | 79.00 | 77.00 | 3.175% | 1.587% | 7.937% | 17.46% | 69.841% | 0.00 | 147.00 | 0.60 | 0.13 | 0.27 | 0.68 | 0.19 | 0.05 | 0.05 | Open | Douglas S. Ingram | Apr 15th, 2024 05:07PM | Apr 15th, 2024 05:07PM | Sarepta Therapeutics | Health Care | Pharmaceuticals & Biotechnology | male | white | ||||||
nasdaq:srpt | https://www.glassdoor.com?employer_id=632730 | 632730 | Apr 14th, 2024 12:00AM | Open | Sarepta Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 1997 | 4.60 | 98% | 96% | 95% | 4.50 | 4.70 | 4.40 | 4.60 | 4.30 | 4.30 | 2.00 | 1.00 | 5.00 | 11.00 | 44.00 | 63.00 | 79.00 | 77.00 | 3.175% | 1.587% | 7.937% | 17.46% | 69.841% | 0.00 | 147.00 | 0.60 | 0.13 | 0.27 | 0.68 | 0.19 | 0.05 | 0.05 | Open | Douglas S. Ingram | Apr 14th, 2024 10:44AM | Apr 14th, 2024 10:44AM | Sarepta Therapeutics | Health Care | Pharmaceuticals & Biotechnology | male | white | ||||||
nasdaq:srpt | https://www.glassdoor.com?employer_id=632730 | 632730 | Apr 13th, 2024 12:00AM | Open | Sarepta Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 1997 | 4.60 | 98% | 96% | 95% | 4.50 | 4.70 | 4.40 | 4.60 | 4.30 | 4.30 | 2.00 | 1.00 | 5.00 | 11.00 | 44.00 | 63.00 | 79.00 | 77.00 | 3.175% | 1.587% | 7.937% | 17.46% | 69.841% | 0.00 | 147.00 | 0.60 | 0.13 | 0.27 | 0.68 | 0.19 | 0.05 | 0.05 | Open | Douglas S. Ingram | Apr 13th, 2024 11:14AM | Apr 13th, 2024 11:14AM | Sarepta Therapeutics | Health Care | Pharmaceuticals & Biotechnology | male | white | ||||||
nasdaq:srpt | https://www.glassdoor.com?employer_id=632730 | 632730 | Apr 12th, 2024 12:00AM | Open | Sarepta Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 1997 | 4.60 | 98% | 96% | 95% | 4.50 | 4.70 | 4.40 | 4.60 | 4.30 | 4.30 | 2.00 | 1.00 | 5.00 | 11.00 | 44.00 | 63.00 | 79.00 | 77.00 | 3.175% | 1.587% | 7.937% | 17.46% | 69.841% | 0.00 | 50.00 | 147.00 | 0.60 | 0.13 | 0.27 | 0.68 | 0.19 | 0.05 | 0.05 | Open | Douglas S. Ingram | Apr 12th, 2024 08:14AM | Apr 12th, 2024 08:14AM | Sarepta Therapeutics | Health Care | Pharmaceuticals & Biotechnology | male | white |